These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [Multiaxial evaluation of the pathophysiology of mood disorder and therapeutic mechanisms of clinical drugs by neuronal plasticity and neuronal load]. Omata N; Mizuno T; Mitsuya H; Wada Y Nihon Shinkei Seishin Yakurigaku Zasshi; 2013 Nov; 33(5-6):231-6. PubMed ID: 25069263 [TBL] [Abstract][Full Text] [Related]
9. [Guidelines for the prescription of mood stabilizers for adolescents: A literature review]. Munch G; Godart N Encephale; 2017 Oct; 43(5):464-470. PubMed ID: 27871720 [TBL] [Abstract][Full Text] [Related]
10. Prevalence, diagnosis, and pharmacological treatment of mood disorders in HIV disease. Cruess DG; Evans DL; Repetto MJ; Gettes D; Douglas SD; Petitto JM Biol Psychiatry; 2003 Aug; 54(3):307-16. PubMed ID: 12893106 [TBL] [Abstract][Full Text] [Related]
11. Emerging experimental therapeutics for bipolar disorder: clues from the molecular pathophysiology. Quiroz JA; Singh J; Gould TD; Denicoff KD; Zarate CA; Manji HK Mol Psychiatry; 2004 Aug; 9(8):756-76. PubMed ID: 15136795 [TBL] [Abstract][Full Text] [Related]
12. The promise of ketamine for treatment-resistant depression: current evidence and future directions. DeWilde KE; Levitch CF; Murrough JW; Mathew SJ; Iosifescu DV Ann N Y Acad Sci; 2015 May; 1345(1):47-58. PubMed ID: 25649308 [TBL] [Abstract][Full Text] [Related]
14. Recurrent cases of corticosteroid-induced mood disorder: clinical characteristics and treatment. Wada K; Yamada N; Suzuki H; Lee Y; Kuroda S J Clin Psychiatry; 2000 Apr; 61(4):261-7. PubMed ID: 10830146 [TBL] [Abstract][Full Text] [Related]
15. Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: update 2007. Yatham LN; Kennedy SH; O'Donovan C; Parikh SV; MacQueen G; McIntyre RS; Sharma V; Beaulieu S; Bipolar Disord; 2006 Dec; 8(6):721-39. PubMed ID: 17156158 [TBL] [Abstract][Full Text] [Related]
16. Mixed features in major depressive disorder: diagnoses and treatments. Suppes T; Ostacher M CNS Spectr; 2017 Apr; 22(2):155-160. PubMed ID: 28462772 [TBL] [Abstract][Full Text] [Related]
17. Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis. Benazzi F; Berk M; Frye MA; Wang W; Barraco A; Tohen M J Clin Psychiatry; 2009 Oct; 70(10):1424-31. PubMed ID: 19906346 [TBL] [Abstract][Full Text] [Related]
18. Guideline for treatment of bipolar disorder by the Japanese Society of Mood Disorders, 2012. Kanba S; Kato T; Terao T; Yamada K; Psychiatry Clin Neurosci; 2013 Jul; 67(5):285-300. PubMed ID: 23773266 [TBL] [Abstract][Full Text] [Related]
19. Treatment of schizoaffective disorder and schizophrenia with mood symptoms. Levinson DF; Umapathy C; Musthaq M Am J Psychiatry; 1999 Aug; 156(8):1138-48. PubMed ID: 10450252 [TBL] [Abstract][Full Text] [Related]
20. A case series on the hypothesized connection between dementia and bipolar spectrum disorders: bipolar type VI? Ng B; Camacho A; Lara DR; Brunstein MG; Pinto OC; Akiskal HS J Affect Disord; 2008 Apr; 107(1-3):307-15. PubMed ID: 17889374 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]